Ronchese F, D'Andrea E, Collavo D, De Rossi A, Zanovello P, Chieco-Bianchi L
Cell Immunol. 1984 Feb;83(2):379-88. doi: 10.1016/0008-8749(84)90317-4.
In virus-positive (V+) C57BL/6 Mov-13 mice, Moloney-murine leukemia virus (M-MuLV) is integrated into the germ line and expressed early in lymphoid and nonlymphoid organs. The pattern of immune reactivity to viral antigens in these mice was studied and compared to that of their virus-negative (V-) counterparts. Using a radioimmuno-binding or -precipitation assay, V- mice showed good antibody production after challenge with Moloney-murine sarcoma virus (M-MSV), but no antibodies were detected in V+ mice. Moreover, Mov-13 V+ mice failed to generate virus-specific cytotoxic T lymphocytes (CTL) in secondary mixed-leukocyte tumor cell culture (MLTC) while V- mice showed a strong cytotoxic response. This lack of activity in mass V+ cultures was due to a very low frequency of CTL precursors which did not increase following in vivo challenge with M-MSV or in vitro stimulation with MBL-2 Moloney leukemia cell line. These findings indicate that early M-MuLV activation in Mov-13 V+ mice induces a state of tolerance to viral antigens involving both the humoral and cellular immune responses and related to the high incidence of T-cell lymphomas.
在病毒阳性(V+)的C57BL/6 Mov-13小鼠中,莫洛尼鼠白血病病毒(M-MuLV)整合到种系中,并在淋巴器官和非淋巴器官中早期表达。研究了这些小鼠对病毒抗原的免疫反应模式,并与病毒阴性(V-)的同窝小鼠进行了比较。使用放射免疫结合或沉淀试验,V-小鼠在用莫洛尼鼠肉瘤病毒(M-MSV)攻击后显示出良好的抗体产生,但在V+小鼠中未检测到抗体。此外,Mov-13 V+小鼠在二次混合淋巴细胞肿瘤细胞培养(MLTC)中未能产生病毒特异性细胞毒性T淋巴细胞(CTL),而V-小鼠则表现出强烈的细胞毒性反应。大量V+培养物中这种活性的缺乏是由于CTL前体的频率非常低,在用M-MSV进行体内攻击或用MBL-2莫洛尼白血病细胞系进行体外刺激后,该频率并未增加。这些发现表明,Mov-13 V+小鼠中早期M-MuLV激活诱导了对病毒抗原的耐受状态,涉及体液免疫和细胞免疫反应,并且与T细胞淋巴瘤的高发病率有关。